Walgreens Boots Alliance (NASDAQ:WBA) Price Target Raised to $8.00 at Barclays

Walgreens Boots Alliance (NASDAQ:WBA) had its price objective upped by Barclays from $7.00 to $8.00 in a research note published on Wednesday morning, Benzinga reports. They currently have an underweight rating on the pharmacy operator’s stock.

A number of other analysts also recently commented on WBA. Evercore ISI boosted their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday. JPMorgan Chase & Co. decreased their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. TD Cowen lowered their price target on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Thursday, September 12th. Morgan Stanley dropped their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a report on Friday, October 11th. Finally, Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research note on Monday, October 7th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $13.54.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $11.07 on Wednesday. The business has a 50-day moving average of $9.41 and a 200-day moving average of $13.22. The company has a market capitalization of $9.56 billion, a price-to-earnings ratio of -1.64, a PEG ratio of 1.06 and a beta of 0.70. Walgreens Boots Alliance has a 1-year low of $8.22 and a 1-year high of $27.05. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating the consensus estimate of $0.36 by $0.03. The company had revenue of $37.50 billion during the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business’s revenue was up 5.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.67 earnings per share. On average, equities analysts anticipate that Walgreens Boots Alliance will post 2.85 EPS for the current fiscal year.

Institutional Investors Weigh In On Walgreens Boots Alliance

Hedge funds and other institutional investors have recently made changes to their positions in the business. Shilanski & Associates Inc. increased its holdings in Walgreens Boots Alliance by 5.3% in the 1st quarter. Shilanski & Associates Inc. now owns 11,821 shares of the pharmacy operator’s stock valued at $256,000 after buying an additional 591 shares during the period. First Trust Direct Indexing L.P. lifted its position in shares of Walgreens Boots Alliance by 1.9% in the 1st quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock worth $696,000 after purchasing an additional 597 shares during the period. Buckley Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 2.1% in the 1st quarter. Buckley Wealth Management LLC now owns 37,335 shares of the pharmacy operator’s stock worth $810,000 after purchasing an additional 785 shares during the period. FinTrust Capital Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 60.4% in the 1st quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock worth $46,000 after purchasing an additional 802 shares during the period. Finally, True Vision MN LLC lifted its position in shares of Walgreens Boots Alliance by 3.3% in the 1st quarter. True Vision MN LLC now owns 26,137 shares of the pharmacy operator’s stock worth $567,000 after purchasing an additional 830 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.